GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3

CRMD financial changes

Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.

Search securities →
CRMDCorMedix Inc.
MEDIUM IMPORTANCER And DR And D Acceleration75TH HISTORICAL PCTL

Research & development increased 173.6%

Research & development changed +173.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.

$2.4M$6.7M4 prior comparisons

Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.